Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes

Volker Jungmann; István Molnár; Philip E. Hammer; D. Steven Hill; Ross Zirkle; Thomas G. Buckel; Dagmar Buckel; James M. Ligon; J. Paul Pachlatko

doi:10.1128/AEM.71.11.6968-6976.2005

Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes

Volker Jungmann, István Molnár (Corresponding Author), Philip E. Hammer, D. Steven Hill, Ross Zirkle, Thomas G. Buckel, Dagmar Buckel, James M. Ligon, J. Paul Pachlatko (Corresponding Author)

Not published at VTT

Research output: Contribution to journal › Article › Scientific › peer-review

10 Citations (Scopus)

Abstract

4″-Oxo-avermectin is a key intermediate in the manufacture of the agriculturally important insecticide emamectin benzoate from the natural product avermectin. Seventeen biocatalytically active Streptomyces strains with the ability to oxidize avermectin to 4″-oxo-avermectin in a regioselective manner have been discovered in a screen of 3,334 microorganisms. The enzymes responsible for this oxidation reaction in these biocatalytically active strains were found to be cytochrome P450 monooxygenases (CYPs) and were termed Ema1 to Ema17. The genes for Ema1 to Ema17 have been cloned, sequenced, and compared to reveal a new subfamily of CYPs. Ema1 to Ema16 have been overexpressed in Escherichia coli and purified as His-tagged recombinant proteins, and their basic enzyme kinetic parameters have been determined.

Original language	English
Pages (from-to)	6968-6976
Number of pages	9
Journal	Applied and Environmental Microbiology
Volume	71
Issue number	11
DOIs	https://doi.org/10.1128/AEM.71.11.6968-6976.2005
Publication status	Published - Nov 2005
MoE publication type	A1 Journal article-refereed

Access to Document

10.1128/AEM.71.11.6968-6976.2005

Cite this

Jungmann, V., Molnár, I., Hammer, P. E., Hill, D. S., Zirkle, R., Buckel, T. G., Buckel, D., Ligon, J. M., & Pachlatko, J. P. (2005). Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes. Applied and Environmental Microbiology, 71(11), 6968-6976. https://doi.org/10.1128/AEM.71.11.6968-6976.2005

@article{1a0db895c9a94a02ab21d215e0ccd701,

title = "Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes",

abstract = "4″-Oxo-avermectin is a key intermediate in the manufacture of the agriculturally important insecticide emamectin benzoate from the natural product avermectin. Seventeen biocatalytically active Streptomyces strains with the ability to oxidize avermectin to 4″-oxo-avermectin in a regioselective manner have been discovered in a screen of 3,334 microorganisms. The enzymes responsible for this oxidation reaction in these biocatalytically active strains were found to be cytochrome P450 monooxygenases (CYPs) and were termed Ema1 to Ema17. The genes for Ema1 to Ema17 have been cloned, sequenced, and compared to reveal a new subfamily of CYPs. Ema1 to Ema16 have been overexpressed in Escherichia coli and purified as His-tagged recombinant proteins, and their basic enzyme kinetic parameters have been determined.",

author = "Volker Jungmann and Istv{\'a}n Moln{\'a}r and Hammer, {Philip E.} and Hill, {D. Steven} and Ross Zirkle and Buckel, {Thomas G.} and Dagmar Buckel and Ligon, {James M.} and Pachlatko, {J. Paul}",

year = "2005",

month = nov,

doi = "10.1128/AEM.71.11.6968-6976.2005",

language = "English",

volume = "71",

pages = "6968--6976",

journal = "Applied and Environmental Microbiology",

issn = "0099-2240",

publisher = "American Society for Microbiology",

number = "11",

}

Jungmann, V, Molnár, I, Hammer, PE, Hill, DS, Zirkle, R, Buckel, TG, Buckel, D, Ligon, JM & Pachlatko, JP 2005, 'Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes', Applied and Environmental Microbiology, vol. 71, no. 11, pp. 6968-6976. https://doi.org/10.1128/AEM.71.11.6968-6976.2005

Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes. / Jungmann, Volker; Molnár, István (Corresponding Author); Hammer, Philip E. et al.
In: Applied and Environmental Microbiology, Vol. 71, No. 11, 11.2005, p. 6968-6976.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Biocatalytic conversion of avermectin to 4″-oxo-avermectin

T2 - Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes

AU - Jungmann, Volker

AU - Molnár, István

AU - Hammer, Philip E.

AU - Hill, D. Steven

AU - Zirkle, Ross

AU - Buckel, Thomas G.

AU - Buckel, Dagmar

AU - Ligon, James M.

AU - Pachlatko, J. Paul

PY - 2005/11

Y1 - 2005/11

N2 - 4″-Oxo-avermectin is a key intermediate in the manufacture of the agriculturally important insecticide emamectin benzoate from the natural product avermectin. Seventeen biocatalytically active Streptomyces strains with the ability to oxidize avermectin to 4″-oxo-avermectin in a regioselective manner have been discovered in a screen of 3,334 microorganisms. The enzymes responsible for this oxidation reaction in these biocatalytically active strains were found to be cytochrome P450 monooxygenases (CYPs) and were termed Ema1 to Ema17. The genes for Ema1 to Ema17 have been cloned, sequenced, and compared to reveal a new subfamily of CYPs. Ema1 to Ema16 have been overexpressed in Escherichia coli and purified as His-tagged recombinant proteins, and their basic enzyme kinetic parameters have been determined.

AB - 4″-Oxo-avermectin is a key intermediate in the manufacture of the agriculturally important insecticide emamectin benzoate from the natural product avermectin. Seventeen biocatalytically active Streptomyces strains with the ability to oxidize avermectin to 4″-oxo-avermectin in a regioselective manner have been discovered in a screen of 3,334 microorganisms. The enzymes responsible for this oxidation reaction in these biocatalytically active strains were found to be cytochrome P450 monooxygenases (CYPs) and were termed Ema1 to Ema17. The genes for Ema1 to Ema17 have been cloned, sequenced, and compared to reveal a new subfamily of CYPs. Ema1 to Ema16 have been overexpressed in Escherichia coli and purified as His-tagged recombinant proteins, and their basic enzyme kinetic parameters have been determined.

UR - http://www.scopus.com/inward/record.url?scp=32044440744&partnerID=8YFLogxK

U2 - 10.1128/AEM.71.11.6968-6976.2005

DO - 10.1128/AEM.71.11.6968-6976.2005

M3 - Article

C2 - 16269732

AN - SCOPUS:32044440744

SN - 0099-2240

VL - 71

SP - 6968

EP - 6976

JO - Applied and Environmental Microbiology

JF - Applied and Environmental Microbiology

IS - 11

ER -

Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this